BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11928871)

  • 1. Expression of p53 protein and tumor angiogenesis as prognostic factors in nasopharyngeal carcinoma patients.
    Rubio L; Burgos JS; Lopez-Guerrero JA; Morera C; Vera-Sempere FJ
    Pathol Res Pract; 2002; 198(2):97-102. PubMed ID: 11928871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 overexpression in nasopharyngeal carcinoma.
    Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
    In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
    Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ
    Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
    Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505.
    Foote RL; Weidner N; Harris J; Hammond E; Lewis JE; Vuong T; Ang KK; Fu KK
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):745-53. PubMed ID: 15708253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
    Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
    J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Am J Otolaryngol; 2006; 27(2):101-5. PubMed ID: 16500472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A risk model for non-small cell lung cancer using clinicopathological variables, angiogenesis and oncoprotein expression.
    Rubio L; Vera-Sempere FJ; Lopez-Guerrero JA; Padilla J; Moreno-Baylach MJ
    Anticancer Res; 2005; 25(1B):497-504. PubMed ID: 15816618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
    Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
    Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary tumours neoangiogenesis and P53 expression in oral carcinoma patients.
    Grammatica L; Piepoli S; D'Auria C; Achille G; Marzullo F; Zito FA; Labriola A; Salvatore C; Paradiso A
    J Exp Clin Cancer Res; 2001 Jun; 20(2):225-30. PubMed ID: 11484979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric study of tumor angiogenesis as a new prognostic factor in nasopharyngeal carcinoma patients.
    Rubio L; Burgos JS; Morera C; Vera-Sempere FJ
    Pathol Oncol Res; 2000; 6(3):210-6. PubMed ID: 11033462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
    Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
    J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
    Zhu Y; Zhou XY; Yao XD; Dai B; Ye DW
    BJU Int; 2007 Jul; 100(1):204-8. PubMed ID: 17433031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel density is a prognostic indicator for patients with astroglial brain tumors.
    Leon SP; Folkerth RD; Black PM
    Cancer; 1996 Jan; 77(2):362-72. PubMed ID: 8625246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
    Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
    Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
    Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.